title: Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo.
abstract: It has been recognized for nearly 80 years that insoluble aluminum salts are good immunologic adjuvants and that they form long-lived nodules in vivo. Nodule formation has long been presumed to be central for adjuvant activity by providing an antigen depot, but the composition and function of these nodules is poorly understood. We show here that aluminum salt nodules formed within hours of injection and contained the clotting protein fibrinogen. Fibrinogen was critical for nodule formation and required processing to insoluble fibrin by thrombin. DNase treatment partially disrupted the nodules, and the nodules contained histone H3 and citrullinated H3, features consistent with extracellular traps. Although neutrophils were not essential for nodule formation, CD11b(+) cells were implicated. Vaccination of fibrinogen-deficient mice resulted in normal CD4 T-cell and antibody responses and enhanced CD8 T-cell responses, indicating that nodules are not required for aluminum's adjuvant effect. Moreover, the ability of aluminum salts to retain antigen in the body, the well-known depot effect, was unaffected by the absence of nodules. We conclude that aluminum adjuvants form fibrin-dependent nodules in vivo, that these nodules have properties of extracellular traps, and the nodules are not required for aluminum salts to act as adjuvants.
authors.affiliation: Department of Immunology, Howard Hughes Medical Institute, Denver, CO 80206, USA.
authors.forename: Michael W
authors.initials: MW
authors.lastname: Munks
authors.forename: Amy S
authors.initials: AS
authors.lastname: McKee
authors.forename: Megan K
authors.initials: MK
authors.lastname: Macleod
authors.forename: Roger L
authors.initials: RL
authors.lastname: Powell
authors.forename: Jay L
authors.initials: JL
authors.lastname: Degen
authors.forename: Nichole A
authors.initials: NA
authors.lastname: Reisdorph
authors.forename: John W
authors.initials: JW
authors.lastname: Kappler
authors.forename: Philippa
authors.initials: P
authors.lastname: Marrack
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000494:pharmacology; D000535:Aluminum / Q000008:administration & dosage* / Q000494:pharmacology; D000818:Animals; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006657:Histones / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D012492:Salts; D013601:T-Lymphocytes / Q000276:immunology; D013917:Thrombin / Q000378:metabolism; D014611:Vaccination
chemical_list: D000276:Adjuvants, Immunologic; D006657:Histones; D012492:Salts; D005337:Fibrin; D005340:Fibrinogen; D000535:Aluminum; D013917:Thrombin